Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Cara Therapeutics | CARA | 24. dec 2024 | 0.46 | +1.36 |
Caravelle International Group | CACO | 24. dec 2024 | 0.44 | 0.00 |
Carbon Revolution | CREV | 24. dec 2024 | 9.16 | +135.48 |
Cardiff Oncology | CRDF | 24. dec 2024 | 3.92 | -3.69 |
Cardinal Health | CAH | 24. dec 2024 | 118.83 | +0.41 |
Cardio Diagnostics | CDIO | 24. dec 2024 | 1.01 | -1.94 |
Cardiol Therapeutics | CRDL | 24. dec 2024 | 1.26 | +0.80 |
Cardlytics | CDLX | 24. dec 2024 | 3.87 | +0.26 |
CareCloud | CCLD | 24. dec 2024 | 3.95 | +6.76 |
CareCloud A Pref | CCLDP | 24. dec 2024 | 18.25 | +0.22 |
CareCloud B Pref | CCLDO | 24. dec 2024 | 18.30 | +1.32 |
CareDx | CDNA | 24. dec 2024 | 21.42 | +2.34 |
CareMax A | CMAX | 24. dec 2024 | 0.42 | 0.00 |
CareTrust REIT | CTRE | 24. dec 2024 | 27.39 | +0.62 |
CARGO Therapeutics | CRGX | 24. dec 2024 | 14.66 | -0.41 |
CarGurus A | CARG | 24. dec 2024 | 36.54 | +1.73 |
Caribou Biosciences | CRBU | 24. dec 2024 | 1.69 | -5.59 |
Carisma Therapeutics | CARM | 24. dec 2024 | 0.40 | +2.84 |
Carlisle Companies | CSL | 24. dec 2024 | 376.45 | -0.02 |
Carlyle Credit Income Fund | CCIF | 24. dec 2024 | 8.06 | +1.00 |
Carlyle Credit Income Fund | CCIA | 24. dec 2024 | 25.71 | +0.04 |
Carlyle Secured Lending | CGBD | 24. dec 2024 | 18.04 | +0.95 |
CarMax | KMX | 24. dec 2024 | 84.91 | +1.45 |
Carmell | CTCX | 24. dec 2024 | 0.28 | +26.20 |
Carnival | CCL | 24. dec 2024 | 25.79 | +0.23 |
Carnival ADR | CUK | 24. dec 2024 | 23.25 | -0.34 |
CarParts.com | PRTS | 24. dec 2024 | 0.92 | -1.98 |
Carpenter Technology | CRS | 24. dec 2024 | 174.52 | +1.11 |
Carriage Services | CSV | 24. dec 2024 | 40.32 | +0.57 |
Carrier Global | CARR | 24. dec 2024 | 69.45 | +0.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.